APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetic Retinopathy Screening Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Diabetic Retinopathy Screening Solution Market Analysis and Forecast 2026-2032

5 June 2026181 pages

Choose your research edition.

Industry ResearchDiabetic Retinopathy Screening Solution Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetic Retinopathy Screening Solution Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Diabetic Retinopathy Screening Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetic Retinopathy Screening Solution Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetic Retinopathy Screening Solution Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Diabetic Retinopathy Screening Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Diabetic Retinopathy Screening Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Diabetic Retinopathy Screening Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Diabetic Retinopathy Screening Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Diabetic Retinopathy Screening Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Diabetic Retinopathy Screening Solution include RETINA-AI Health, IRIS, Retina Labs, CheckEye, RetinaLyze, NEC Software, InHealth Intelligence, RetinaRisk and Thirona Retina, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Diabetic Retinopathy Screening Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Diabetic Retinopathy Screening Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Diabetic Retinopathy Screening Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetic Retinopathy Screening Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diabetic Retinopathy Screening Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Diabetic Retinopathy Screening Solution revenue, projected growth trends, production technology, application and end-user industry.

Diabetic Retinopathy Screening Solution Segment by Company

RETINA-AI Health

IRIS

Retina Labs

CheckEye

RetinaLyze

NEC Software

InHealth Intelligence

RetinaRisk

Thirona Retina

Synapxe

Eyenuk

EyRIS (SELENA+)

Vistel

Diabetic Retinopathy Screening Solution Segment by Type

Traditional

Artificial Intelligence

Others

Diabetic Retinopathy Screening Solution Segment by Application

Medical Industry

Scientific Research

Others

Diabetic Retinopathy Screening Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Screening Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Screening Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Screening Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Diabetic Retinopathy Screening Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Diabetic Retinopathy Screening Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Retinopathy Screening Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Traditional Major Player Table 3. Artificial Intelligence Major Player Table 4. Others Major Player Table 5. Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medical Industry Major Player Table 7. Scientific Research Major Player Table 8. Others Major Player Table 9. Diabetic Retinopathy Screening Solution Industry Trends Table 10. Diabetic Retinopathy Screening Solution Industry Drivers Table 11. Diabetic Retinopathy Screening Solution Industry Opportunities and Challenges Table 12. Diabetic Retinopathy Screening Solution Industry Restraints Table 13. Global Diabetic Retinopathy Screening Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Diabetic Retinopathy Screening Solution Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Diabetic Retinopathy Screening Solution Market Share by Region (2021-2026) Table 16. Global Diabetic Retinopathy Screening Solution Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Diabetic Retinopathy Screening Solution Market Share by Region (2027-2032) Table 18. Global Diabetic Retinopathy Screening Solution Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Players (2021-2026) Table 20. Global Diabetic Retinopathy Screening Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Diabetic Retinopathy Screening Solution Key Players Headquarters & Area Served Table 22. Global Diabetic Retinopathy Screening Solution Players, Product Type & Application Table 23. Global Diabetic Retinopathy Screening Solution Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Diabetic Retinopathy Screening Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Diabetic Retinopathy Screening Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Type (2021-2026) Table 30. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Type (2027-2032) Table 31. Global Diabetic Retinopathy Screening Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Application (2021-2026) Table 35. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Application (2027-2032) Table 36. RETINA-AI Health Company Information Table 37. RETINA-AI Health Business Overview Table 38. RETINA-AI Health Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. RETINA-AI Health Diabetic Retinopathy Screening Solution Product Portfolio Table 40. RETINA-AI Health Recent Development Table 41. IRIS Company Information Table 42. IRIS Business Overview Table 43. IRIS Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. IRIS Diabetic Retinopathy Screening Solution Product Portfolio Table 45. IRIS Recent Development Table 46. Retina Labs Company Information Table 47. Retina Labs Business Overview Table 48. Retina Labs Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Retina Labs Diabetic Retinopathy Screening Solution Product Portfolio Table 50. Retina Labs Recent Development Table 51. CheckEye Company Information Table 52. CheckEye Business Overview Table 53. CheckEye Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CheckEye Diabetic Retinopathy Screening Solution Product Portfolio Table 55. CheckEye Recent Development Table 56. RetinaLyze Company Information Table 57. RetinaLyze Business Overview Table 58. RetinaLyze Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. RetinaLyze Diabetic Retinopathy Screening Solution Product Portfolio Table 60. RetinaLyze Recent Development Table 61. NEC Software Company Information Table 62. NEC Software Business Overview Table 63. NEC Software Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. NEC Software Diabetic Retinopathy Screening Solution Product Portfolio Table 65. NEC Software Recent Development Table 66. InHealth Intelligence Company Information Table 67. InHealth Intelligence Business Overview Table 68. InHealth Intelligence Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. InHealth Intelligence Diabetic Retinopathy Screening Solution Product Portfolio Table 70. InHealth Intelligence Recent Development Table 71. RetinaRisk Company Information Table 72. RetinaRisk Business Overview Table 73. RetinaRisk Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. RetinaRisk Diabetic Retinopathy Screening Solution Product Portfolio Table 75. RetinaRisk Recent Development Table 76. Thirona Retina Company Information Table 77. Thirona Retina Business Overview Table 78. Thirona Retina Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Thirona Retina Diabetic Retinopathy Screening Solution Product Portfolio Table 80. Thirona Retina Recent Development Table 81. Synapxe Company Information Table 82. Synapxe Business Overview Table 83. Synapxe Diabetic Retinopathy Screening Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Synapxe Diabetic Retinopathy Screening Solution Product Portfolio Table 85. Synapxe Recent Development Table 86. Eyenuk Company Information Table 87. Eyenuk Business Overview Table 88. Eyenuk Diabetic Retinopathy Screening Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Eyenuk Diabetic Retinopathy Screening Solution Product Portfolio Table 90. Eyenuk Recent Development Table 91. EyRIS (SELENA+) Company Information Table 92. EyRIS (SELENA+) Business Overview Table 93. EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product Portfolio Table 95. EyRIS (SELENA+) Recent Development Table 96. Vistel Company Information Table 97. Vistel Business Overview Table 98. Vistel Diabetic Retinopathy Screening Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Vistel Diabetic Retinopathy Screening Solution Product Portfolio Table 100. Vistel Recent Development Table 101. North America Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Diabetic Retinopathy Screening Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Diabetic Retinopathy Screening Solution Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Diabetic Retinopathy Screening Solution Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Diabetic Retinopathy Screening Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Diabetic Retinopathy Screening Solution Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Diabetic Retinopathy Screening Solution Revenue by Country (US$ Million) & (2027-2032) Table 115. China Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026) & (US$ Million) Table 116. China Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032) & (US$ Million) Table 117. China Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026) & (US$ Million) Table 118. China Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Diabetic Retinopathy Screening Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Diabetic Retinopathy Screening Solution Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Diabetic Retinopathy Screening Solution Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Diabetic Retinopathy Screening Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Diabetic Retinopathy Screening Solution Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Diabetic Retinopathy Screening Solution Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Diabetic Retinopathy Screening Solution Image Figure 2. Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diabetic Retinopathy Screening Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Traditional Image Figure 5. Artificial Intelligence Image Figure 6. Others Image Figure 7. Global Diabetic Retinopathy Screening Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Diabetic Retinopathy Screening Solution Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medical Industry Image Figure 10. Scientific Research Image Figure 11. Others Image Figure 12. Global Diabetic Retinopathy Screening Solution Market Size (US$ Million) & (2021-2032) Figure 13. Global Diabetic Retinopathy Screening Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Diabetic Retinopathy Screening Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Diabetic Retinopathy Screening Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Diabetic Retinopathy Screening Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Diabetic Retinopathy Screening Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Type (2021-2032) Figure 20. Global Diabetic Retinopathy Screening Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Diabetic Retinopathy Screening Solution Revenue Market Share by Application (2021-2032) Figure 23. North America Diabetic Retinopathy Screening Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032) Figure 25. North America Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032) Figure 26. North America Diabetic Retinopathy Screening Solution Revenue Share by Country (2021-2032) Figure 27. United States Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Diabetic Retinopathy Screening Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032) Figure 32. Europe Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032) Figure 33. Europe Diabetic Retinopathy Screening Solution Revenue Share by Country (2021-2032) Figure 34. Germany Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Diabetic Retinopathy Screening Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032) Figure 44. China Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032) Figure 45. Asia Diabetic Retinopathy Screening Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032) Figure 47. Asia Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032) Figure 48. Asia Diabetic Retinopathy Screening Solution Revenue Share by Region (2021-2032) Figure 49. Japan Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Diabetic Retinopathy Screening Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032) Figure 57. SAMEA Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032) Figure 58. SAMEA Diabetic Retinopathy Screening Solution Revenue Share by Country (2021-2032) Figure 59. Brazil Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Diabetic Retinopathy Screening Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional
  • Artificial Intelligence
  • Others
Applications
  • Medical Industry
  • Scientific Research
  • Others
Companies covered
  • RETINA-AI Health
  • IRIS
  • Retina Labs
  • CheckEye
  • RetinaLyze
  • NEC Software
  • InHealth Intelligence
  • RetinaRisk
  • Thirona Retina
  • Synapxe
  • Eyenuk
  • EyRIS (SELENA+)
  • Vistel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Diabetic Retinopathy Screening Solution Market by Type
  3. 1.2.1 Global Diabetic Retinopathy Screening Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Traditional
  5. 1.2.3 Artificial Intelligence
  6. 1.2.4 Others
  7. 1.3 Diabetic Retinopathy Screening Solution Market by Application
  8. 1.3.1 Global Diabetic Retinopathy Screening Solution Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Industry
  10. 1.3.3 Scientific Research
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Diabetic Retinopathy Screening Solution Market Dynamics
  1. 2.1 Diabetic Retinopathy Screening Solution Industry Trends
  2. 2.2 Diabetic Retinopathy Screening Solution Industry Drivers
  3. 2.3 Diabetic Retinopathy Screening Solution Industry Opportunities and Challenges
  4. 2.4 Diabetic Retinopathy Screening Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Diabetic Retinopathy Screening Solution Market Perspective (2021-2032)
  2. 3.2 Global Diabetic Retinopathy Screening Solution Growth Trends by Region
  3. 3.2.1 Global Diabetic Retinopathy Screening Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Diabetic Retinopathy Screening Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Diabetic Retinopathy Screening Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Diabetic Retinopathy Screening Solution Revenue by Players
  2. 4.1.1 Global Diabetic Retinopathy Screening Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Diabetic Retinopathy Screening Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Diabetic Retinopathy Screening Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Diabetic Retinopathy Screening Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Diabetic Retinopathy Screening Solution Key Players Headquarters & Area Served
  7. 4.4 Global Diabetic Retinopathy Screening Solution Players, Product Type & Application
  8. 4.5 Global Diabetic Retinopathy Screening Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Diabetic Retinopathy Screening Solution Market CR5 and HHI
  11. 4.6.3 2025 Diabetic Retinopathy Screening Solution Tier 1, Tier 2, and Tier 3
5 Diabetic Retinopathy Screening Solution Market Size by Type
  1. 5.1 Global Diabetic Retinopathy Screening Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Diabetic Retinopathy Screening Solution Revenue by Type (2021-2032)
  3. 5.3 Global Diabetic Retinopathy Screening Solution Revenue Market Share by Type (2021-2032)
6 Diabetic Retinopathy Screening Solution Market Size by Application
  1. 6.1 Global Diabetic Retinopathy Screening Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Diabetic Retinopathy Screening Solution Revenue by Application (2021-2032)
  3. 6.3 Global Diabetic Retinopathy Screening Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 RETINA-AI Health
  2. 7.1.1 RETINA-AI Health Company Information
  3. 7.1.2 RETINA-AI Health Business Overview
  4. 7.1.3 RETINA-AI Health Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 RETINA-AI Health Diabetic Retinopathy Screening Solution Product Portfolio
  6. 7.1.5 RETINA-AI Health Recent Developments
  7. 7.2 IRIS
  8. 7.2.1 IRIS Company Information
  9. 7.2.2 IRIS Business Overview
  10. 7.2.3 IRIS Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 IRIS Diabetic Retinopathy Screening Solution Product Portfolio
  12. 7.2.5 IRIS Recent Developments
  13. 7.3 Retina Labs
  14. 7.3.1 Retina Labs Company Information
  15. 7.3.2 Retina Labs Business Overview
  16. 7.3.3 Retina Labs Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Retina Labs Diabetic Retinopathy Screening Solution Product Portfolio
  18. 7.3.5 Retina Labs Recent Developments
  19. 7.4 CheckEye
  20. 7.4.1 CheckEye Company Information
  21. 7.4.2 CheckEye Business Overview
  22. 7.4.3 CheckEye Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CheckEye Diabetic Retinopathy Screening Solution Product Portfolio
  24. 7.4.5 CheckEye Recent Developments
  25. 7.5 RetinaLyze
  26. 7.5.1 RetinaLyze Company Information
  27. 7.5.2 RetinaLyze Business Overview
  28. 7.5.3 RetinaLyze Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 RetinaLyze Diabetic Retinopathy Screening Solution Product Portfolio
  30. 7.5.5 RetinaLyze Recent Developments
  31. 7.6 NEC Software
  32. 7.6.1 NEC Software Company Information
  33. 7.6.2 NEC Software Business Overview
  34. 7.6.3 NEC Software Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NEC Software Diabetic Retinopathy Screening Solution Product Portfolio
  36. 7.6.5 NEC Software Recent Developments
  37. 7.7 InHealth Intelligence
  38. 7.7.1 InHealth Intelligence Company Information
  39. 7.7.2 InHealth Intelligence Business Overview
  40. 7.7.3 InHealth Intelligence Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 InHealth Intelligence Diabetic Retinopathy Screening Solution Product Portfolio
  42. 7.7.5 InHealth Intelligence Recent Developments
  43. 7.8 RetinaRisk
  44. 7.8.1 RetinaRisk Company Information
  45. 7.8.2 RetinaRisk Business Overview
  46. 7.8.3 RetinaRisk Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 RetinaRisk Diabetic Retinopathy Screening Solution Product Portfolio
  48. 7.8.5 RetinaRisk Recent Developments
  49. 7.9 Thirona Retina
  50. 7.9.1 Thirona Retina Company Information
  51. 7.9.2 Thirona Retina Business Overview
  52. 7.9.3 Thirona Retina Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Thirona Retina Diabetic Retinopathy Screening Solution Product Portfolio
  54. 7.9.5 Thirona Retina Recent Developments
  55. 7.10 Synapxe
  56. 7.10.1 Synapxe Company Information
  57. 7.10.2 Synapxe Business Overview
  58. 7.10.3 Synapxe Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Synapxe Diabetic Retinopathy Screening Solution Product Portfolio
  60. 7.10.5 Synapxe Recent Developments
  61. 7.11 Eyenuk
  62. 7.11.1 Eyenuk Company Information
  63. 7.11.2 Eyenuk Business Overview
  64. 7.11.3 Eyenuk Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Eyenuk Diabetic Retinopathy Screening Solution Product Portfolio
  66. 7.11.5 Eyenuk Recent Developments
  67. 7.12 EyRIS (SELENA+)
  68. 7.12.1 EyRIS (SELENA+) Company Information
  69. 7.12.2 EyRIS (SELENA+) Business Overview
  70. 7.12.3 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  71. 7.12.4 EyRIS (SELENA+) Diabetic Retinopathy Screening Solution Product Portfolio
  72. 7.12.5 EyRIS (SELENA+) Recent Developments
  73. 7.13 Vistel
  74. 7.13.1 Vistel Company Information
  75. 7.13.2 Vistel Business Overview
  76. 7.13.3 Vistel Diabetic Retinopathy Screening Solution Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Vistel Diabetic Retinopathy Screening Solution Product Portfolio
  78. 7.13.5 Vistel Recent Developments
8 North America
  1. 8.1 North America Diabetic Retinopathy Screening Solution Revenue (2021-2032)
  2. 8.2 North America Diabetic Retinopathy Screening Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032)
  5. 8.3 North America Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Diabetic Retinopathy Screening Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032)
  9. 8.5 North America Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Diabetic Retinopathy Screening Solution Revenue by Country
  11. 8.6.1 North America Diabetic Retinopathy Screening Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Diabetic Retinopathy Screening Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Diabetic Retinopathy Screening Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Diabetic Retinopathy Screening Solution Revenue (2021-2032)
  2. 9.2 Europe Diabetic Retinopathy Screening Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Diabetic Retinopathy Screening Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Diabetic Retinopathy Screening Solution Revenue by Country
  11. 9.6.1 Europe Diabetic Retinopathy Screening Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Diabetic Retinopathy Screening Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Diabetic Retinopathy Screening Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Diabetic Retinopathy Screening Solution Revenue (2021-2032)
  2. 10.2 China Diabetic Retinopathy Screening Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032)
  5. 10.3 China Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Diabetic Retinopathy Screening Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032)
  9. 10.5 China Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Diabetic Retinopathy Screening Solution Revenue (2021-2032)
  2. 11.2 Asia Diabetic Retinopathy Screening Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Diabetic Retinopathy Screening Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Diabetic Retinopathy Screening Solution Revenue by Country
  11. 11.6.1 Asia Diabetic Retinopathy Screening Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Diabetic Retinopathy Screening Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Diabetic Retinopathy Screening Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Diabetic Retinopathy Screening Solution Revenue (2021-2032)
  2. 12.2 SAMEA Diabetic Retinopathy Screening Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Diabetic Retinopathy Screening Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Diabetic Retinopathy Screening Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Diabetic Retinopathy Screening Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Diabetic Retinopathy Screening Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Diabetic Retinopathy Screening Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Diabetic Retinopathy Screening Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Diabetic Retinopathy Screening Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Diabetic Retinopathy Screening Solution Revenue by Country
  11. 12.6.1 SAMEA Diabetic Retinopathy Screening Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Diabetic Retinopathy Screening Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Diabetic Retinopathy Screening Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst